These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9855863)

  • 1. Genetic risk factors in the development of heart disease: familial hypercholesterolemia and hyperhomocysteinemia.
    LaCharity LA
    AACN Clin Issues; 1998 Nov; 9(4):531-8. PubMed ID: 9855863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.
    Gidding SS; Champagne MA; de Ferranti SD; Defesche J; Ito MK; Knowles JW; McCrindle B; Raal F; Rader D; Santos RD; Lopes-Virella M; Watts GF; Wierzbicki AS;
    Circulation; 2015 Dec; 132(22):2167-92. PubMed ID: 26510694
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.
    McGowan MP; Hosseini Dehkordi SH; Moriarty PM; Duell PB
    J Am Heart Assoc; 2019 Dec; 8(24):e013225. PubMed ID: 31838973
    [No Abstract]   [Full Text] [Related]  

  • 4. [Genetic testing in cardiologic diagnostics].
    Heliö T; Aalto-Setälä K
    Duodecim; 2010; 126(14):1685-92. PubMed ID: 20804087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013.
    Mundal L; Igland J; Ose L; Holven KB; Veierød MB; Leren TP; Retterstøl K
    Eur J Prev Cardiol; 2017 Jan; 24(2):137-144. PubMed ID: 27794106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypercholesterolemia: a challenge of diagnosis and therapy.
    Sibley C; Stone NJ
    Cleve Clin J Med; 2006 Jan; 73(1):57-64. PubMed ID: 16444917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of registries and genetic databases in familial hypercholesterolemia.
    Kindt I; Mata P; Knowles JW
    Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study.
    Frich JC; Ose L; Malterud K; Fugelli P
    Ann Fam Med; 2006; 4(3):198-204. PubMed ID: 16735520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology.
    Safarova MS; Kullo IJ
    Circ Res; 2018 Jan; 122(1):26-27. PubMed ID: 29301842
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial hypercholesterolemia--we must act boldly.
    Moodie D
    Congenit Heart Dis; 2014; 9(4):273-4. PubMed ID: 25099345
    [No Abstract]   [Full Text] [Related]  

  • 11. [First Brazilian Guidelines for Familial Hypercholesterolemia].
    Santos RD; Gagliardi AC; Xavier HT; Casella Filho A; Araújo DB; Cesena FY; Alves RJ; ; Pereira AC; Lottemberg AM; Chacra AP; Faludi AA; Sposito AC; Ribeiro Filho FF; Helfenstein Fonseca FA; de Carlos Back Giuliano I; Catani LH; Bertolami MC; Hiroshi Miname M; Izar MC; Monte O; Maranhão RC; Martinez TL; Arruda Machado V; Zorzanelli Rocha V; Salgado Filho W;
    Arq Bras Cardiol; 2012 Aug; 99(2 Suppl 2):1-28. PubMed ID: 23532256
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia.
    Banach M; Penson PE
    Eur J Prev Cardiol; 2022 May; 29(5):718-720. PubMed ID: 33624078
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic screening and treatment in familial hypercholesterolemia].
    Leren TP; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 2001 May; 121(13):1635-6. PubMed ID: 11446055
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop.
    Bild DE; Williams RR; Brewer HB; Herd JA; Pearson TA; Stein E
    Am J Cardiol; 1993 Sep; 72(10):1D-5D. PubMed ID: 8105671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?
    Paynter NP; Ridker PM; Chasman DI
    Circ Res; 2016 Feb; 118(4):607-19. PubMed ID: 26892961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and cardiovascular disease: a review of current recommendations for screening and treatment.
    Chamberlain KL
    J Am Acad Nurse Pract; 2005 Mar; 17(3):90-5. PubMed ID: 15748221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia: stroke and the broader perspective.
    Meschia JF
    Stroke; 2003 Jan; 34(1):22-5. PubMed ID: 12511735
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid apheresis in the treatment of patients with severe, refractory hypercholesterolemia.
    Tecnologica MAP Suppl; 1999 Apr; ():15-7. PubMed ID: 10848165
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperlipidemia and cardiovascular disease with focus on familial hypercholesterolemia.
    Holven KB; Ulven SM; Bogsrud MP
    Curr Opin Lipidol; 2017 Oct; 28(5):445-447. PubMed ID: 28857860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.